Stock ADK DIAGNOS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages DIAGNOS Inc.

Equities

ADK

CA2524423068

Delayed Toronto S.E.
Other stock markets
 19:51:21 03/05/2024 BST 		5-day change 1st Jan Change
0.32 CAD +6.67% Intraday chart for DIAGNOS Inc. +14.29% -20.99%
04-16 DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification CI
04-02 DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification
DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors
Diagnos Announces Grant Of Stock Options
DIAGNOS Inc. Appoints Michael Braeuel to Board of Directors
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
DIAGNOS Announces Closing Of First Tranche Of Private Placement
Diagnos Inc. Appoints Yves-Stéphane Couture as Chief Operating Officer
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
DIAGNOS : 2023-10-05, L’analyse de la rétine par DIAGNOS IA est en cours de déploiement chez le plus grand fournisseur de soins spécialisés en diabète et en endocrinologie au Canada – En savoir plus
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt
DIAGNOS : 2023-05-17, DIAGNOS et IRIS, Le Groupe Visuel renforcent leur partenariat avec le lancement de « IRIS-ai propulsé par DIAGNOS » – En savoir plus
Diagnos Announces Launch of "IRIS-ai powered by DIAGNOS"
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS"
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADK Stock
  4. News DIAGNOS Inc.
  5. Other languages